|
|
Article: Deltagen Enters Into Gene Function Database and Target Validation Agreements with Glaxo Wellcome.
- Article from:
- PR Newswire
- Article date:
- September 6, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- First Information Set of Data Points for Targeted Genes Has Been Delivered -
MENLO PARK, Calif., Sept. 6 /PRNewswire/ --
Deltagen, Inc. (Nasdaq: DGEN) today announced that it entered into two agreements with Glaxo Wellcome involving Deltagen's DeltaBase(TM) gene function database and Deltagen's DeltaSelect(TM) target validation program. The first installment of the DeltaBase database has been delivered to Glaxo Wellcome, containing gene function information for potential new drug targets.
Glaxo Wellcome is the first subscriber to Deltagen's DeltaBase database for mammalian gene function. Glaxo Wellcome will have non-exclusive access to in ...